Retrieve available abstracts of 16 articles: HTML format
Single Articles
May 2025
SINISCALCHI C, Di Micco P, Tufano A, Peris ML, et al Baseline Hemoglobin Values and Clinical Outcomes in Acute Venous Thromboembolism:
Insights From the RIETE Registry.
Am J Hematol. 2025 May 13. doi: 10.1002/ajh.27707. PubMed
January 2025
LI Y, Sun F, Ji C, Yang H, et al Association of Sleep Traits With Venous Thromboembolism: Prospective Cohort and
Mendelian Randomization Studies.
Am J Hematol. 2025 Jan 30. doi: 10.1002/ajh.27620. PubMedAbstract available
HU Z, Xu J, Shen R, Lin L, et al Combination of Biological Aging and Genetic Susceptibility Helps Identifying
At-Risk Population of Venous Thromboembolism: A Prospective Cohort Study of
394 041 Participants.
Am J Hematol. 2025 Jan 22. doi: 10.1002/ajh.27605. PubMedAbstract available
MAHMOUD A, Luo S, Gage BF, Afzal A, et al Association Between Anticoagulant-Related Bleeding and Mortality in Patients With
Solid Tumors and Cancer-Associated Venous Thromboembolism.
Am J Hematol. 2025 Jan 21. doi: 10.1002/ajh.27588. PubMed
LECUMBERRI R, Ruiz-Artacho P, Trujillo-Santos J, Marcos-Jubilar M, et al Impact of Baseline Thrombocytopenia on Early Outcomes in Patients With Acute
Venous Thromboembolism.
Am J Hematol. 2025 Jan 10. doi: 10.1002/ajh.27579. PubMedAbstract available
May 2024
SIDDIQUI F, Tafur A, Hussain M, Garcia-Ortega A, et al The prognostic value of blood cellular indices in pulmonary embolism.
Am J Hematol. 2024 May 30. doi: 10.1002/ajh.27379. PubMedAbstract available
SARTORI M, Iotti M, Camporese G, Siragusa S, et al Six-week low-molecular-weight heparin versus 12-week warfarin for calf deep vein
thrombosis: A randomized, prospective, open-label study.
Am J Hematol. 2024;99:854-861. PubMedAbstract available
April 2024
MA S, La J, Swinnerton KN, Guffey D, et al Thrombosis risk prediction in lymphoma patients: A multi-institutional,
retrospective model development and validation study.
Am J Hematol. 2024 Apr 23. doi: 10.1002/ajh.27335. PubMedAbstract available
March 2024
COSTA BA, Costa TA, Saravia SD, Felix N, et al Thromboembolic risk of carfilzomib or bortezomib in combination with lenalidomide
and dexamethasone for newly diagnosed multiple myeloma: A comparative systematic
review and meta-analysis.
Am J Hematol. 2024 Mar 15. doi: 10.1002/ajh.27288. PubMedAbstract available
January 2024
ROY DC, Wang TF, Lun R, Zharai A, et al Inherited thrombophilia gene mutations and risk of venous thromboembolism in
patients with cancer: A systematic review and meta-analysis.
Am J Hematol. 2024 Jan 30. doi: 10.1002/ajh.27222. PubMedAbstract available
October 2023
GUE YX, Lip GYH Increased risk of venous thromboembolism in patients with gastrointestinal
disorders.
Am J Hematol. 2023 Oct 19. doi: 10.1002/ajh.27140. PubMed
September 2023
YUAN S, Sun Y, Chen J, Li X, et al Long-term risk of venous thromboembolism among patients with gastrointestinal
non-neoplastic and neoplastic diseases: A prospective cohort study of 484 211
individuals.
Am J Hematol. 2023 Sep 27. doi: 10.1002/ajh.27106. PubMedAbstract available
August 2023
AGARWAL S, Stanek JR, Vesely SK, Creary SE, et al Pregnancy-related thromboembolism in women with sickle cell disease: An analysis
of National Medicaid Data.
Am J Hematol. 2023 Aug 8. doi: 10.1002/ajh.27045. PubMedAbstract available
June 2023
GIORGIO K, Walker RF, MacLehose RF, Adrianzen-Herrera D, et al Venous thromboembolism mortality and trends in older US adults, 2011-2019.
Am J Hematol. 2023 Jun 27. doi: 10.1002/ajh.26996. PubMedAbstract available
WANG TF, Grubic N, Carrier M, Canney M, et al Risk of venous thromboembolism or hemorrhage among individuals with chronic
kidney disease on prophylactic anticoagulant after hip or knee arthroplasty.
Am J Hematol. 2023 Jun 21. doi: 10.1002/ajh.26994. PubMedAbstract available
May 2023
LI A, May SB, La J, Martens KL, et al Venous thromboembolism risk in cancer patients receiving first-line immune
checkpoint inhibitor versus chemotherapy.
Am J Hematol. 2023 May 10. doi: 10.1002/ajh.26954. PubMedAbstract available